Leveraging Infographics and Search for Better Health Communications: Epilepsy Foundation/Lundbeck Case Study
One example of how pharma companies can use infographics to educate their stakeholders is the Epilepsy Foundation/Lundbeck nationwide initiative to bring information about managing seizures to people living with epilepsy and their families. This article discusses how Centric Infographics worked with the Foundation to create the infographic system at the center of this successful campaign.
Welcome to Volume 13, Issue #7 (AUGUST 2014) of Pharma Marketing News.
These days, patient storytelling is all the rage. More often than not, however, patient stories told by pharma marketers are not 'providing truth' in the sense that they are real patient stories.
A Public Affairs Specialist at FDA's Center for Drug Evaluation and Research (CDER) confirmed to several reporters that this guidance is actually PART of the long-awaited guidance that was promised after the November, 2009 public hearing and required by section 1121 of the Prescription Drug User Fee Act (PDUFA).
This article is a review of FDA's proposed study titled 'Spousal Influence on Consumer Understanding of and Response to Direct-To-Consumer Prescription Drug Advertisements' (FDA-2014-N-1819)
Welcome to Volume 13, Issue #5 (May 2014) of Pharma Marketing News.
Welcome to Volume 13, Issue #8 (SEPTEMBER 2014) of Pharma Marketing News.
According to Lea Katsanis, PhD, Marketing Professor at Concordia University's John Molson School of Business, developing a strong brand personality is an important way that pharmaceutical marketers can increase brand loyalty, brand trust, and ultimately brand equity.
Social Media, Latent Spokespersons & Native Advertising: Questions Raised by FDA Guidelines with Answers,...
This article focuses on a few of the issues, gray areas, and questions mentioned during the 'Green light or go slow' webcast and also in comments submitted to the FDA.